164 related articles for article (PubMed ID: 28640064)
1. Predictors of Local Recurrence in Patients With Myxofibrosarcoma.
Odei B; Rwigema JC; Eilber FR; Eilber FC; Selch M; Singh A; Chmielowski B; Nelson SD; Wang PC; Steinberg M; Kamrava M
Am J Clin Oncol; 2018 Sep; 41(9):827-831. PubMed ID: 28640064
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and outcomes of patients with myxofibrosarcoma.
Look Hong NJ; Hornicek FJ; Raskin KA; Yoon SS; Szymonifka J; Yeap B; Chen YL; DeLaney TF; Nielsen GP; Mullen JT
Ann Surg Oncol; 2013 Jan; 20(1):80-6. PubMed ID: 22890594
[TBL] [Abstract][Full Text] [Related]
3. Soft tissue myxofibrosarcoma: A clinico-pathological analysis of a series of 75 patients with emphasis on the epithelioid variant.
Scoccianti G; Ranucci V; Frenos F; Greto D; Beltrami G; Capanna R; Franchi A
J Surg Oncol; 2016 Jul; 114(1):50-5. PubMed ID: 27076198
[TBL] [Abstract][Full Text] [Related]
4. A clinicopathologic examination of myxofibrosarcoma. Do surgical margins significantly affect local recurrence rates in this infiltrative sarcoma subtype?
Dadrass F; Gusho C; Yang F; Culvern C; Bloom J; Fillingham Y; Colman M; Gitelis S; Blank A
J Surg Oncol; 2021 Feb; 123(2):489-496. PubMed ID: 33125727
[TBL] [Abstract][Full Text] [Related]
5. Grading in Myxofibrosarcoma of the Extremities Can Predict Survival and Local Control.
Sambri A; Tuzzato G; Spinnato P; De Paolis M; Donati DM; Bianchi G
Oncol Res Treat; 2020; 43(5):189-195. PubMed ID: 32268331
[TBL] [Abstract][Full Text] [Related]
6. Surgical margins do not affect prognosis in high grade myxofibrosarcoma.
Sambri A; Bianchi G; Righi A; Ferrari C; Donati D
Eur J Surg Oncol; 2016 Jul; 42(7):1042-8. PubMed ID: 27260849
[TBL] [Abstract][Full Text] [Related]
7. Influence of site on the therapeutic ratio of adjuvant radiotherapy in soft-tissue sarcoma of the extremity.
Alektiar KM; Brennan MF; Singer S
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):202-8. PubMed ID: 16111590
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Factors and Outcomes for Patients With Myxofibrosarcoma: A 13-Year Retrospective Evaluation.
Mühlhofer HML; Lenze U; Gersing A; Lallinger V; Burgkart R; Obermeier A; VON Eisenhart-Rothe R; Knebel C
Anticancer Res; 2019 Jun; 39(6):2985-2992. PubMed ID: 31177139
[TBL] [Abstract][Full Text] [Related]
9. Low-grade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems.
Huang HY; Lal P; Qin J; Brennan MF; Antonescu CR
Hum Pathol; 2004 May; 35(5):612-21. PubMed ID: 15138937
[TBL] [Abstract][Full Text] [Related]
10. Analysis of clinical factors impacting recurrence in myxofibrosarcoma.
Chen W; Ye M; Sun Y; Wei Y; Huang Y
Sci Rep; 2024 Feb; 14(1):3903. PubMed ID: 38365844
[TBL] [Abstract][Full Text] [Related]
11. Localized Myxofibrosarcomas: Roles of Surgical Margins and Adjuvant Radiation Therapy.
Boughzala-Bennadji R; Stoeckle E; Le Péchoux C; Méeus P; Honoré C; Attal J; Duffaud F; De Pinieux G; Bompas E; Thariat J; Leroux A; Bertucci F; Isambert N; Delcambre C; Blay JY; Sunyach MP; Coindre JM; Sargos P; Penel N; Bonvalot S
Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):399-406. PubMed ID: 30191871
[TBL] [Abstract][Full Text] [Related]
12. PROGNOSTIC FACTORS IN PATIENTS WITH APPENDICULAR MYXOFIBROSARCOMA.
Zumárraga JP; Batista FAR; Baptista AM; Caiero MT; Martino LPR; de Camargo OP
Acta Ortop Bras; 2018; 26(5):320-324. PubMed ID: 30464713
[TBL] [Abstract][Full Text] [Related]
13. Soft Tissue Sarcomas of the Extremities: Surgical Margins Can Be Close as Long as the Resected Tumor Has No Ink on It.
Harati K; Goertz O; Pieper A; Daigeler A; Joneidi-Jafari H; Niggemann H; Stricker I; Lehnhardt M
Oncologist; 2017 Nov; 22(11):1400-1410. PubMed ID: 28739867
[TBL] [Abstract][Full Text] [Related]
14. Recurrence patterns and survival for patients with intermediate- and high-grade myxofibrosarcoma.
Haglund KE; Raut CP; Nascimento AF; Wang Q; George S; Baldini EH
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):361-7. PubMed ID: 20951504
[TBL] [Abstract][Full Text] [Related]
15. Systemic Inflammation Is Associated with Oncological Outcome in Patients with High-Grade Myxofibrosarcoma of the Extremities: A Retrospective Analysis.
Sambri A; Zucchini R; Giannini C; Cevolani L; Fiore M; Spinnato P; Bianchi G; Donati DM; De Paolis M
Oncol Res Treat; 2020; 43(10):531-538. PubMed ID: 32810863
[TBL] [Abstract][Full Text] [Related]
16. Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant.
Mentzel T; Calonje E; Wadden C; Camplejohn RS; Beham A; Smith MA; Fletcher CD
Am J Surg Pathol; 1996 Apr; 20(4):391-405. PubMed ID: 8604805
[TBL] [Abstract][Full Text] [Related]
17. The enigma of myxofibrosarcoma of the extremity.
Mutter RW; Singer S; Zhang Z; Brennan MF; Alektiar KM
Cancer; 2012 Jan; 118(2):518-27. PubMed ID: 21717447
[TBL] [Abstract][Full Text] [Related]
18. What is an adequate margin for infiltrative soft-tissue sarcomas?
Fujiwara T; Stevenson J; Parry M; Tsuda Y; Tsoi K; Jeys L
Eur J Surg Oncol; 2020 Feb; 46(2):277-281. PubMed ID: 31627932
[TBL] [Abstract][Full Text] [Related]
19. Head and neck myxofibrosarcoma: a case report and review of the literature.
Dell'Aversana Orabona G; Iaconetta G; Abbate V; Piombino P; Romano A; Maglitto F; Salzano G; Califano L
J Med Case Rep; 2014 Dec; 8():468. PubMed ID: 25547541
[TBL] [Abstract][Full Text] [Related]
20. Myxofibrosarcoma of the extremity and trunk: a multidisciplinary approach leads to good local rates of LOCAL control.
Ghazala CG; Agni NR; Ragbir M; Dildey P; Lee D; Rankin KS; Beckingsale TB; Gerrand CH
Bone Joint J; 2016 Dec; 98-B(12):1682-1688. PubMed ID: 27909132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
